American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 4(66), 2022
DOI: 10.1128/aac.02181-21
Full text: Unavailable
Neonatal sepsis is an underrecognized burden on health care systems throughout the world. Antimicrobial drug resistance (AMR) is increasingly prevalent and compromises the use of currently recommended first-line agents.